The team has experience of undertaking cross border transactions in Europe, Asia Pacific and the USA including acquisitions and disposals and the IPR disposals via licensing or sale. Client highlights and testimonials
Tecrea Limited Advising Tecrea Limited on its spinout from the Royal Veterinary College. Based in the London Bioscience Innovation Centre, its business is to develop technology to improve cell delivery for research and drug development purposes. The arrangements included an assignment of all IPR in respect of the delivery technology. Alderley Analytical Limited Advising Alderley Analytical Limited on its formation and funding round with Alderley Park Ventures and SPARK Impact.
Peak Proteins Limited Advising Peak Proteins Limited on its original incorporation at the Biohub in Alderley Park. The subsequently advised on the investment by Sygil Group Limited. Talisman Therapeutics Limited Advising Talisman Therapeutics Limited on its spin out from Cambridge University including a Collaboration Agreement with MedImmunne. Intercytex Limited Advising Intercytex Limited on the sale of its advanced regenerative medical products marketed as Vavelta to Ember Therapeutics, Inc. for a consideration of up to $4,000,000.
Made with FlippingBook Online newsletter maker